ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,957Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 4623

$1.59M Total Retail Price of All Prescriptions

Rank: 29 out of 4623

875 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

30% of this provider’s 875 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 24,118 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,289 1,036 S3 1 3
LEVOTHYROXINE SODIUM 967 856 2 1
SIMVASTATIN 928 757 3 2
POTASSIUM CHLORIDE 742 642 4 14
DONEPEZIL HCL 685 655 5 30
FUROSEMIDE 653 576 6 8
LISINOPRIL 628 526 7 4
NAMENDA 583 554 8 36
AMLODIPINE BESYLATE 554 492 9 5
GABAPENTIN 541 427 10 16
SERTRALINE HCL 526 394 11 26
METOPROLOL TARTRATE 505 460 12 9
WARFARIN SODIUM 460 395 13 24
METFORMIN HCL 454 337 14 6
MIRTAZAPINE 431 410 15 57
OMEPRAZOLE 414 313 16 7
TRAMADOL HCL 395 306 17 15
CARVEDILOL 377 318 18 25
ZOLPIDEM TARTRATE 330 271 19 18
ATENOLOL 321 278 20 28
CLONIDINE HCL 307 232 21 40
RAMIPRIL 305 273 22 76
CLOPIDOGREL 275 255 23 31
ENALAPRIL MALEATE 270 237 24 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 259 176 25 19
HYDROCHLOROTHIAZIDE 257 206 26 10
LANTUS 256 201 27 44
PAROXETINE HCL 252 221 28 78
DIVALPROEX SODIUM 236 160 29 90
GLIPIZIDE 228 146 30 49
CITALOPRAM HBR 225 185 31 23
RISPERIDONE 219 184 32 72
DIGOXIN 212 190 33 58
TAMSULOSIN HCL 212 189 33 29
PREDNISONE 212 178 33 50
QUETIAPINE FUMARATE 211 194 36 74
ISOSORBIDE MONONITRATE ER 207 178 37 60
EXELON 207 200 37 107
ROPINIROLE HCL 201 173 39 108
KLOR-CON M20 195 160 40 102
CARBIDOPA-LEVODOPA 195 177 40 116
TRAZODONE HCL 195 153 40 42
PRAVASTATIN SODIUM 194 188 43 11
MELOXICAM 180 140 44 27
METOPROLOL SUCCINATE 175 165 45 13
PLAVIX 171 158 46 45
LACTULOSE 170 119 47 106
PHENYTOIN SODIUM EXTENDED 165 117 48 119
NOVOLIN R 163 140 49 113
ALENDRONATE SODIUM 156 152 50 22
CYMBALTA 151 127 51 48
PANTOPRAZOLE SODIUM 148 142 52 35
ALBUTEROL SULFATE 148 141 52 142
DIOVAN 144 129 54 39
LOSARTAN POTASSIUM 144 123 54 21
LEVOFLOXACIN 142 127 56 81
ESCITALOPRAM OXALATE 140 118 57 75
AZITHROMYCIN 138 124 58 33
BUMETANIDE 135 121 59 211
DOXYCYCLINE HYCLATE 131 102 60 101
CEPHALEXIN 130 96 61 84
JANUVIA 128 115 62 52
POLYETHYLENE GLYCOL 3350 122 107 63 91
NEXIUM 119 90 64 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 113 97 65 68
DIOVAN HCT 108 55 66 67
LEVETIRACETAM 107 83 67 114
OLANZAPINE 107 105 67 127
DETROL LA 105 91 69 196
TRIAMTERENE-HCTZ 104 78 70 80
PROMETHAZINE HCL 102 91 R 71 93
LYRICA 102 61 71 66
VENLAFAXINE HCL ER 92 62 73 132
SPIRONOLACTONE 89 59 74 77
LEVEMIR FLEXPEN 89 80 74 167
SEROQUEL 89 75 74 149
FLUOXETINE HCL 89 40 74 61
CYCLOBENZAPRINE HCL 87 44 R 78 53
TERAZOSIN HCL 86 86 79 143
AMOXICILLIN 85 66 80 95
ALLOPURINOL 85 75 80 37
BUSPIRONE HCL 81 73 82 135
CRESTOR 81 73 82 20
ATORVASTATIN CALCIUM 80 73 84 12
AMOX TR-POTASSIUM CLAVULANATE 79 56 85 117
NATEGLINIDE 77 77 86 305
SUCRALFATE 75 68 87 183
FAMOTIDINE 75 56 87 82
OXYBUTYNIN CHLORIDE 75 59 87 120
IBUPROFEN 75 53 87 65
LEVEMIR 73 72 91 154
HYDROXYZINE HCL 73 64 R 91 138
AMITRIPTYLINE HCL 72 46 R 93 69
NIFEDIPINE ER 71 55 94 97
ATENOLOL-CHLORTHALIDONE 68 60 95 195
FLUTICASONE PROPIONATE 67 62 96 32
CIPROFLOXACIN HCL 67 59 96 43
NOVOLIN N 66 62 98 237
COMBIVENT 65 33 99 162
PHENYTOIN 65 49 99 294
METOLAZONE 65 50 99 208
PRIMIDONE 64 37 102 260
PROAIR HFA 64 44 102 64
RANITIDINE HCL 63 52 104 47
LATANOPROST 55 41 105 224
OXYBUTYNIN CHLORIDE ER 55 48 105 163
BUPROPION HCL 55 53 105 368
SPIRIVA 54 49 108 79
IPRATROPIUM-ALBUTEROL 54 48 108 177
ABILIFY 53 41 110 161
HUMALOG 53 46 110 186
MEGESTROL ACETATE 52 48 R 112 145
FLUCONAZOLE 51 32 113 189
NOVOLOG FLEXPEN 51 46 113 206
LOVASTATIN 51 45 113 34
PENTOXIFYLLINE 51 40 113 245
HYDRALAZINE HCL 51 44 113 99
AMIODARONE HCL 50 50 118 207
KLOR-CON M10 50 42 118 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.